Infectious Disease Diagnostics Market
Infectious Disease Diagnostics Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Reagents, Kits, and Consumables, Instruments, Software & Services
- By Type of Testing Laboratory Testing, POC Testing
- By Technology Immunodiagnostics, Clinical Microbiology , PCR , INAAT , DNA Sequencing & NGS , DNA Microarrays , Other technologies
- By Disease Type COVID-19, HIV , HAIs , Hepatitis , CT/NG , HPV , TB , Influenza , Other Infectious Diseases
- By End User Diagnostic Laboratories, Hospitals & Clinics , Academic Research Institutes , Other End Users
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 29632.56 Million |
Revenue 2030: | USD 49041.76 Million |
Revenue CAGR (2023 - 2030): | 6.50% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Infectious Disease Diagnostics Market - Segment Analysis
- Overview
- Global Infectious Disease Diagnostics Market, 2016 - 2028 (USD Million)
-
Global Infectious Disease Diagnostics Market - by Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
-
Global Infectious Disease Diagnostics Market - by Type of Testing
- By Laboratory Testing
- By POC Testing
-
Global Infectious Disease Diagnostics Market - by Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
-
Global Infectious Disease Diagnostics Market - by Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
-
Global Infectious Disease Diagnostics Market - by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
-
Global Infectious Disease Diagnostics Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Infectious Disease Diagnostics Market - Segment Analysis
- Overview
- North America Infectious Disease Diagnostics Market, 2016 - 2028 (USD Million)
-
North America Infectious Disease Diagnostics Market, by Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
-
North America Infectious Disease Diagnostics Market, by Type of Testing
- By Laboratory Testing
- By POC Testing
-
North America Infectious Disease Diagnostics Market, by Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
-
North America Infectious Disease Diagnostics Market, by Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
-
North America Infectious Disease Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
-
North America Infectious Disease Diagnostics Market, by Country
- U.S.
- U.S. Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- U.S. Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- U.S. Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- U.S. Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- U.S. Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- U.S. Infectious Disease Diagnostics Market, By Product
- Canada
- Canada Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Canada Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Canada Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Canada Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Canada Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Canada Infectious Disease Diagnostics Market, By Product
- Mexico
- Mexico Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Mexico Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Mexico Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Mexico Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Mexico Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Mexico Infectious Disease Diagnostics Market, By Product
- U.S.
-
Europe Infectious Disease Diagnostics Market - Segment Analysis
- Overview
- Europe Infectious Disease Diagnostics Market, 2016 - 2028 (USD Million)
-
Europe Infectious Disease Diagnostics Market, by Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
-
Europe Infectious Disease Diagnostics Market, by Type of Testing
- By Laboratory Testing
- By POC Testing
-
Europe Infectious Disease Diagnostics Market, by Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
-
Europe Infectious Disease Diagnostics Market, by Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
-
Europe Infectious Disease Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
-
Europe Infectious Disease Diagnostics Market, by Country
- Germany
- Germany Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Germany Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Germany Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Germany Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Germany Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Germany Infectious Disease Diagnostics Market, By Product
- UK
- UK Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- UK Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- UK Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- UK Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- UK Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- UK Market, By Product
- France
- France Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- France Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- France Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- France Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- France Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- France Infectious Disease Diagnostics Market, By Product
- Spain
- Spain Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Spain Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Spain Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Spain Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Spain Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Spain Infectious Disease Diagnostics Market, By Product
- Italy
- Italy Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Italy Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Italy Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Italy Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Italy Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Italy Infectious Disease Diagnostics Market, By Product
- BENELUX
- BENELUX Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- BENELUX Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- BENELUX Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- BENELUX Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- BENELUX Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- BENELUX Infectious Disease Diagnostics Market, By Product
- Rest of Europe
- Rest Of Europe Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Rest Of Europe Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Rest Of Europe Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Rest Of Europe Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Rest Of Europe Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Rest Of Europe Infectious Disease Diagnostics Market, By Product
- Germany
-
Asia Pacific Infectious Disease Diagnostics Market - Segment Analysis
- Overview
- Asia Pacific Infectious Disease Diagnostics Market, 2016 - 2028 (USD Million)
-
Asia Pacific Infectious Disease Diagnostics Market, by Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
-
Asia Pacific Infectious Disease Diagnostics Market, by Type of Testing
- By Laboratory Testing
- By POC Testing
-
Asia Pacific Infectious Disease Diagnostics Market, by Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
-
Asia Pacific Infectious Disease Diagnostics Market, by Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
-
Asia Pacific Infectious Disease Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
-
Asia Pacific Infectious Disease Diagnostics Market, by Country
- China
- China Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- China Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- China Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- China Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- China Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- China Infectious Disease Diagnostics Market, By Product
- Japan
- Japan Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Japan Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Japan Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Japan Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Japan Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Japan Infectious Disease Diagnostics Market, By Product
- India
- India Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- India Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- India Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- India Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- India Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- India Infectious Disease Diagnostics Market, By Product
- South Korea
- South Korea Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- South Korea Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- South Korea Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- South Korea Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- South Korea Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- South Korea Infectious Disease Diagnostics Market, By Product
- South East Asia
- South East Asia Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- South East Asia Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- South East Asia Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- South East Asia Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- South East Asia Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- South East Asia Infectious Disease Diagnostics Market, By Product
- Rest of Asia Pacific
- Rest of Asia Pacific Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Rest of Asia Pacific Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Rest of Asia Pacific Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Rest of Asia Pacific Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Rest of Asia Pacific Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Rest of Asia Pacific Infectious Disease Diagnostics Market, By Product
- China
-
Latin America Infectious Disease Diagnostics Market - Segment Analysis
- Overview
- Latin America Infectious Disease Diagnostics Market, 2016 - 2028 (USD Million)
-
Latin America Infectious Disease Diagnostics Market, by Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
-
Latin America Infectious Disease Diagnostics Market, by Type of Testing
- By Laboratory Testing
- By POC Testing
-
Latin America Infectious Disease Diagnostics Market, by Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
-
Latin America Infectious Disease Diagnostics Market, by Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
-
Latin America Infectious Disease Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
-
Latin America Infectious Disease Diagnostics Market, by Country
- Brazil
- Brazil Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Brazil Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Brazil Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Brazil Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Brazil Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Brazil Infectious Disease Diagnostics Market, By Product
- Argentina
- Argentina Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Argentina Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Argentina Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Argentina Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Argentina Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Argentina Infectious Disease Diagnostics Market, By Product
- Rest of Latin America
- Rest of Latin America Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Rest of Latin America Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Rest of Latin America Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Rest of Latin America Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Rest of Latin America Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Rest of Latin America Infectious Disease Diagnostics Market, By Product
- Brazil
-
Middle East & Africa Infectious Disease Diagnostics Market - Segment Analysis
- Overview
- Middle East & Africa Infectious Disease Diagnostics Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Infectious Disease Diagnostics Market, by Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
-
Middle East & Africa Infectious Disease Diagnostics Market, by Type of Testing
- By Laboratory Testing
- By POC Testing
-
Middle East & Africa Infectious Disease Diagnostics Market, by Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
-
Middle East & Africa Infectious Disease Diagnostics Market, by Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
-
Middle East & Africa Infectious Disease Diagnostics Market, by End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
-
Middle East & Africa Infectious Disease Diagnostics Market, by Country
- GCC Countries
- GCC Countries Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- GCC Countries Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- GCC Countries Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- GCC Countries Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- GCC Countries Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- GCC Countries Infectious Disease Diagnostics Market, By Product
- South Africa
- South Africa Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- South Africa Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- South Africa Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- South Africa Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- South Africa Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- South Africa Infectious Disease Diagnostics Market, By Product
- Rest of Middle East & Africa
- Rest of Middle East & Africa Infectious Disease Diagnostics Market, By Product
- By Reagents, Kits, and Consumables
- By Instruments
- By Software & Services
- Rest of Middle East & Africa Infectious Disease Diagnostics Market, By Type of Testing
- By Laboratory Testing
- By POC Testing
- Rest of Middle East & Africa Infectious Disease Diagnostics Market, By Technology
- By Immunodiagnostics
- By Clinical Microbiology
- By PCR
- By INAAT
- By DNA Sequencing & NGS
- By DNA Microarrays
- By Other technologies
- Rest of Middle East & Africa Infectious Disease Diagnostics Market, By Disease Type
- By COVID-19
- By HIV
- By HAIs
- By Hepatitis
- By CT/NG
- By HPV
- By TB
- By Influenza
- By Other Infectious Diseases
- Rest of Middle East & Africa Infectious Disease Diagnostics Market, By End User
- By Diagnostic Laboratories
- By Hospitals & Clinics
- By Academic Research Institutes
- By Other End Users
- Rest of Middle East & Africa Infectious Disease Diagnostics Market, By Product
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Abbott Laboratories (US)
- F. Hoffmann-La Roche Ltd(Switzerland)
- bioMérieux SA (France)
- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Quidel Corporation(US)
- Hologic Inc. (US)
- Siemens Healthineers AG (Germany)
- Becton
- Dickinson and Company (US)
- PerkinElmer Inc. (US)
- QIAGEN (Netherlands)
- Grifols S.A. (Spain)
- DiaSorin S.p.A (Italy)
- Bio-Rad Laboratories Inc. (US)
- Sysmex Corporation (Japan)
- Ortho Clinical Diagnostics (US)
- Luminex Corporation (US)
- Meridian Bioscience (US)
- Genetic Signatures (Australia)
- OraSure Technologies (US)
- Trinity Biotech Plc. (Ireland)
- Chembio Diagnostic Systems Inc. (US)
- Seegene Inc. (South Korea)
- Co-Diagnostics Inc. (US)
- ELITechGroup (France)
- Epitope Diagnostics Inc. (US)
- Trivitron Healthcare (India)
- Meril Life Sciences Pvt. Ltd. (India)
- InBios International Inc. (US)
- and ABACUS Diagnostica Oy (Finland).
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Infectious Disease Diagnostics in terms of revenue?
-
The global Infectious Disease Diagnostics valued at USD 29632.56 Million in 2022 and is expected to reach USD 49041.76 Million in 2030 growing at a CAGR of 6.50%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.50% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Infectious Disease Diagnostics include
- increasing prevalence of infectious diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Infectious Disease Diagnostics in 2022.